Paul Volberding, MD
Professor Emeritus
Epidemiology & Biostatistics
School of Medicine

I was the PI and co-director with Warner Greene of the NIAID-funded UCSF-Gladstone Center for AIDS Research supporting the large community of HIV investigators in San Francisco. CFAR provides core services, pilot grants to early career stage investigators and supports a comprehensive mentorship program. In the Clinical and Translational Sciences Institute I served as a member of the Board of Directors and formerly directed the Global Health Program. I stepped down as the Chief of the Medical Service at the San Francisco VA Medical Center in 2012 to become the Director of the UCSF AIDS Research Institute. The ARI is the comprehensive University organization that links all HIV/AIDS research programs and is the central focus for communications, media relations and philanthropic support for this internationally recognized response to the HIV epidemic. In 2015, the ARI became the administrative home for a unique initiative to cure HIV infection funded by amfAR, the Foundation for AIDS Research. I served until recently as the Director of the amfAR Institute for HIV Cure, working with leading scientists at UCSF, the Gladstone Institute for Virology and Immunology, and the Vitalant (formerly the Blood Systems) Research Institute. I also served as the Associate Chair of the UCSF Department of Medicine for Global Health. I am the Clinical Editor in Chief of the Journal of the Acquired Immunodeficiency Syndromes and served as the Chair of the Scientific Advisory Board of the Accordia Global AIDS Foundation and the Infectious Diseases Institute at Makerere University in Kampala Uganda. I was a board member of the Pangaea Global AIDS Foundation. I am an active member of the National Academy of Medicine (formerly the Institute of Medicine) of the National Academy of Sciences and am the founding Board Chair of the International Antiviral Society-USA. On Twitter I am @pvolberding.

• Transcriptomic Signatures of Human Immunodeficiency Virus Post-Treatment Control.
  Journal of virology 2022 Wedrychowski A, Martin HA, Li Y, Telwatte S, Kadiyala GN, Melberg M, Etemad B, Connick E, Jacobson JM, Margolis DM, Skiest D, Volberding P, Hecht F, Deeks S, Wong JK, Li JZ, Yukl SA
• Sexual Practice Changes Post-HIV Diagnosis Among Men Who Have Sex with Men in the United States: A Systematic Review and Meta-analysis.
  AIDS and behavior 2022 Malekinejad M, Jimsheleishvili S, Barker EK, Hutchinson AB, Shrestha RK, Volberding P, Kahn JG
• Is France Once Again Looking for a Scapegoat?
  Pathogens & immunity 2021 Lederman MM, Flier JS, Hale P, Haase AT, Powderly W, Reiss P, Silvestri G, Sekaly RP, Paiardini M, Weissman D, Kuritzkes DR, Calabrese LH, Agre P, Reyes-Teran G, Landay AL, Lewin S, Richman DD, …
• Frequency of post treatment control varies by antiretroviral therapy restart and viral load criteria.
  AIDS (London, England) 2021 Fajnzylber J, Sharaf R, Hutchinson JN, Aga E, Bosch RJ, Hartogensis W, Jacobson JM, Connick E, Volberding P, Skiest DJ, Margolis D, Sneller MC, Little SJ, Gulick RM, Mellors JW, Gandhi RT, Schooley RT…
• The relationship of smoking and unhealthy alcohol use to the HIV care continuum among people with HIV in an integrated health care system.
  Drug and alcohol dependence 2021 Satre DD, Levine-Hall T, Sterling SA, Young-Wolff KC, Lam JO, Alexeeff S, Hojilla JC, Williams A, Justice AC, Sterne J, Cavassini M, Bryant KJ, Williams EC, Horberg MA, Volberding P, Weisner C, …
• Change in Condom Use in Populations Newly Aware of HIV Diagnosis in the United States and Canada: A Systematic Review and Meta-Analysis.
  AIDS and behavior 2021 Malekinejad M, Blodgett J, Horvath H, Parriott A, Hutchinson AB, Shrestha RK, McCabe D, Volberding P, Kahn JG
• Health care utilization and HIV clinical outcomes among newly enrolled patients following Affordable Care Act implementation in a California integrated health system: a longitudinal study.
  BMC health services research 2020 Satre DD, Parthasarathy S, Silverberg MJ, Horberg M, Young-Wolff KC, Williams EC, Volberding P, Campbell CI
• Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel.
  JAMA 2020 Saag MS, Gandhi RT, Hoy JF, Landovitz RJ, Thompson MA, Sax PE, Smith DM, Benson CA, Buchbinder SP, Del Rio C, Eron JJ, Fätkenheuer G, Günthard HF, Molina JM, Jacobsen DM, Volberding PA
• Sharing Experiences and Lessons: Medical Issues in Confronting the HIV Epidemic and COVID-19.
  International journal of radiation oncology, biology, physics 2020 Volberding P
• Antiretroviral drug class and anaemia risk in the current treatment era among people living with HIV in the USA: a clinical cohort study.
  BMJ open 2020 Harding BN, Whitney BM, Nance RM, Crane HM, Burkholder G, Moore RD, Mathews WC, Eron JJ, Hunt PW, Volberding P, Rodriguez B, Mayer K, Saag MS, Kitahata MM, Heckbert SR, Delaney JAC
• Antimicrobial Drug Development Efficiency and Surrogate Markers of Clinical Benefit.
  JAMA internal medicine 2020 Volberding P, Chambers HF
• National Academies Consensus Report on Functional Assessment for Adults With Disabilities.
  Archives of physical medicine and rehabilitation 2019 Heinemann AW, Volberding PA
• Implementing electronic substance use disorder and depression and anxiety screening and behavioral interventions in primary care clinics serving people with HIV: Protocol for the Promoting Access to Care Engagement (PACE) trial.
  Contemporary clinical trials 2019 Satre DD, Anderson AN, Leibowitz AS, Levine-Hall T, Slome S, Flamm J, Hare CB, McNeely J, Weisner CM, Horberg MA, Volberding P, Silverberg MJ
• HIV Screening and Preexposure Prophylaxis Guidelines: Following the Evidence.
  JAMA 2019 Scott H, Volberding PA
• Interventions to Reduce Unhealthy Alcohol Use among Primary Care Patients with HIV: the Health and Motivation Randomized Clinical Trial.
  Journal of general internal medicine 2019 Satre DD, Leibowitz AS, Leyden W, Catz SL, Hare CB, Jang H, Lam JO, Bryant KJ, Weisner CM, Sterling SA, Horberg M, Volberding P, Silverberg MJ
• Cost-effectiveness of Hepatitis B Virus Infection Screening and Treatment or Vaccination in 6 High-risk Populations in the United States.
  Open forum infectious diseases 2018 Chahal HS, Peters MG, Harris AM, McCabe D, Volberding P, Kahn JG
• The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies.
  The Journal of infectious diseases 2018 Namazi G, Fajnzylber JM, Aga E, Bosch RJ, Acosta EP, Sharaf R, Hartogensis W, Jacobson JM, Connick E, Volberding P, Skiest D, Margolis D, Sneller MC, Little SJ, Gianella S, Smith DM, Kuritzkes DR, …
• HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers.
  The Journal of clinical investigation 2018 Sharaf R, Lee GQ, Sun X, Etemad B, Aboukhater LM, Hu Z, Brumme ZL, Aga E, Bosch RJ, Wen Y, Namazi G, Gao C, Acosta EP, Gandhi RT, Jacobson JM, Skiest D, Margolis DM, Mitsuyasu R, Volberding P, Connick…
• Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel.
  JAMA 2018 Saag MS, Benson CA, Gandhi RT, Hoy JF, Landovitz RJ, Mugavero MJ, Sax PE, Smith DM, Thompson MA, Buchbinder SP, Del Rio C, Eron JJ, Fätkenheuer G, Günthard HF, Molina JM, Jacobsen DM, Volberding PA
• Effect of Short-Term Antiretroviral Therapy Interruption on Levels of Integrated HIV DNA.
  Journal of virology 2018 Strongin Z, Sharaf R, VanBelzen DJ, Jacobson JM, Connick E, Volberding P, Skiest DJ, Gandhi RT, Kuritzkes DR, O'Doherty U, Li JZ
• A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care.
  Topics in antiviral medicine 2017 Benson CA, Currier JS, Del Rio C, Gallant JE, Gulick RM, Marrazzo JM, Richman DD, Saag MS, Schooley RT, Volberding PA
• Effectiveness of community-based condom distribution interventions to prevent HIV in the United States: A systematic review and meta-analysis.
  PloS one 2017 Malekinejad M, Parriott A, Blodgett JC, Horvath H, Shrestha RK, Hutchinson AB, Volberding P, Kahn JG
• How to Survive a Plague: The Next Great HIV/AIDS History.
  JAMA 2017 Volberding PA
• HIV Treatment and Prevention: An Overview of Recommendations From the IAS-USA Antiretroviral Guidelines Panel.
  Topics in antiviral medicine 2017 Volberding PA
• JAIDS: Transitions, Evolution, and Impact.
  Journal of acquired immune deficiency syndromes (1999) 2017 Volberding P, Blattner WA
• Implementation and Operational Research: Affordable Care Act Implementation in a California Health Care System Leads to Growth in HIV-Positive Patient Enrollment and Changes in Patient Characteristics.
  Journal of acquired immune deficiency syndromes (1999) 2016 Satre DD, Altschuler A, Parthasarathy S, Silverberg MJ, Volberding P, Campbell CI
• Facilitators of HCV treatment adherence among people who inject drugs: a systematic qualitative review and implications for scale up of direct acting antivirals.
  BMC public health 2016 Rich ZC, Chu C, Mao J, Zhou K, Cai W, Ma Q, Volberding P, Tucker JD
• Long-term survival in AIDS-related primary central nervous system lymphoma.
  Neuro-oncology 2016 Gupta NK, Nolan A, Omuro A, Reid EG, Wang CC, Mannis G, Jaglal M, Chavez JC, Rubinstein PG, Griffin A, Abrams DI, Hwang J, Kaplan LD, Luce JA, Volberding P, Treseler PA, Rubenstein JL
• Health impact of human rights testimony: harming the most vulnerable?
  BMJ global health 2016 Meffert SM, Shome S, Neylan TC, Musalo K, Fineberg HV, Cooke MM, Volberding PA, Goosby EP
• Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel.
  JAMA 2016 Günthard HF, Saag MS, Benson CA, del Rio C, Eron JJ, Gallant JE, Hoy JF, Mugavero MJ, Sax PE, Thompson MA, Gandhi RT, Landovitz RJ, Smith DM, Jacobsen DM, Volberding PA
• Hepatitis C Virus Treatment Access Among Human Immunodeficiency Virus and Hepatitis C Virus (HCV)-Coinfected People Who Inject Drugs in Guangzhou, China: Implications for HCV Treatment Expansion.
  Open forum infectious diseases 2016 Chu CE, Wu F, He X, Zhou K, Cheng Y, Cai W, Geng E, Volberding P, Tucker JD
• Crowdsourcing HIV Test Promotion Videos: A Noninferiority Randomized Controlled Trial in China.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016 Tang W, Han L, Best J, Zhang Y, Mollan K, Kim J, Liu F, Hudgens M, Bayus B, Terris-Prestholt F, Galler S, Yang L, Peeling R, Volberding P, Ma B, Xu H, Yang B, Huang S, Fenton K, Wei C, Tucker JD
• Building Networks for Global Clinical Research: The Basics.
  Journal of orthopaedic trauma 2015 Shearer DW, Volberding PA, Schemitsch EH, Cook GE, Slobogean GP, Morshed S
• Implementing Implementation Science: An Approach for HIV Prevention, Care and Treatment Programs.
  Current HIV research 2015 Lambdin BH, Cheng B, Peter T, Mbwambo J, Apollo T, Dunbar M, Udoh IC, Cattamanchi A, Geng EH, Volberding P
• Highlights of the 2014 International AIDS Conference: update from down under.
  Topics in antiviral medicine 2014 Volberding PA
• Words matter: Discussing research towards an HIV cure in research and clinical contexts.
  Journal of acquired immune deficiency syndromes (1999) 2014 Tucker JD, Volberding PA, Margolis DM, Rennie S, Barré-Sinoussi F
• Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel.
  JAMA 2014 Günthard HF, Aberg JA, Eron JJ, Hoy JF, Telenti A, Benson CA, Burger DM, Cahn P, Gallant JE, Glesby MJ, Reiss P, Saag MS, Thomas DL, Jacobsen DM, Volberding PA, International Antiviral Society-USA …
• Solving the mystery of JAIDS.
  Journal of acquired immune deficiency syndromes (1999) 2013 Volberding PA
• Bringing the end in sight: consensus regarding HIV screening strategies.
  Annals of internal medicine 2013 Das M, Volberding P
• A chronicle of hope and promise: the world as it was, as it is, and as it can be.
  Journal of acquired immune deficiency syndromes (1999) 2012 El-Sadr WM, Morrison JS, Quinn T, Volberding P
• Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.
  JAMA 2012 Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, Cahn P, Eron JJ, Günthard HF, Hammer SM, Reiss P, Richman DD, Rizzardini G, Thomas DL, Jacobsen DM, Volberding PA
• HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group.
  Journal of acquired immune deficiency syndromes (1999) 2012 High KP, Brennan-Ing M, Clifford DB, Cohen MH, Currier J, Deeks SG, Deren S, Effros RB, Gebo K, Goronzy JJ, Justice AC, Landay A, Levin J, Miotti PG, Munk RJ, Nass H, Rinaldo CR, Shlipak MG, Tracy R, …
• Augmented HIV-specific interferon-gamma responses, but impaired lymphoproliferation during interruption of antiretroviral treatment initiated in primary HIV infection.
  Journal of acquired immune deficiency syndromes (1999) 2011 Connick E, Bosch RJ, Aga E, Schlichtemeier R, Demeter LM, Volberding P, ACTG 709 Team
• Clinician attitudes about commercial support of continuing medical education: results of a detailed survey.
  Archives of internal medicine 2011 Tabas JA, Boscardin C, Jacobsen DM, Steinman MA, Volberding PA, Baron RB
• HIV and premature aging: A field still in its infancy.
  Annals of internal medicine 2010 Martin J, Volberding P
• Prevalence of primary resistance at baseline in acutely and recently infected subjects enrolled in AIDS clinical trials group protocol 371.
  Journal of acquired immune deficiency syndromes (1999) 2010 Dykes C, Mukherjee AL, Bosch RJ, Connick E, Volberding PA, Demeter LM
• Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.
  JAMA 2010 Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A, Gatell JM, Günthard HF, Hammer SM, Hirsch MS, Jacobsen DM, Reiss P, Richman DD, Volberding PA, Yeni P, Schooley RT, International …
• Antiretroviral therapy and management of HIV infection.
  Lancet (London, England) 2010 Volberding PA, Deeks SG
• Long-term clinical consequences of acute kidney injury in the HIV-infected.
  Kidney international 2010 Choi AI, Li Y, Parikh C, Volberding PA, Shlipak MG
• Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons.
  Circulation 2010 Choi AI, Li Y, Deeks SG, Grunfeld C, Volberding PA, Shlipak MG
• Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment.
  AIDS (London, England) 2009 Volberding P, Demeter L, Bosch RJ, Aga E, Pettinelli C, Hirsch M, Vogler M, Martinez A, Little S, Connick E, ACTG 371 Team
• Cohorts, trials, and evidence: expanding our confidence in guidelines for antiretroviral resistance testing.
  Annals of internal medicine 2009 Volberding P
• Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.
  JAMA 2008 Hammer SM, Eron JJ, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS, Jacobsen DM, Montaner JS, Richman DD, Yeni PG, Volberding PA, International AIDS Society-USA
• Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007 Choi AI, Rodriguez RA, Bacchetti P, Volberding PA, Havlir D, Bertenthal D, Bostrom A, O'Hare AM
• Racial differences in end-stage renal disease rates in HIV infection versus diabetes.
  Journal of the American Society of Nephrology : JASN 2007 Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Volberding PA, O'Hare AM
• Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007 Behler CM, Vittinghoff E, Lin F, Chung RT, Peters MG, Robbins GK, Volberding PA
• Relationship between antiretroviral prescribing patterns and treatment guidelines in treatment-naive HIV-1-infected US veterans (1992-2004).
  Journal of acquired immune deficiency syndromes (1999) 2007 Holodniy M, Hornberger J, Rapoport D, Robertus K, MaCurdy TE, Lopez J, Volberding P, Deyton L
• Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.
  JAMA 2006 Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, Thompson MA, Carpenter CC, Fischl MA, Gazzard BG, Gatell JM, Hirsch MS, Katzenstein DA, Richman DD, Vella S, Yeni PG, Volberding…
• Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel.
  Topics in HIV medicine : a publication of the International AIDS Society, USA 2006 Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, Thompson MA, Carpenter CC, Fischl MA, Gazzard BG, Gatell JM, Hirsch MS, Katzenstein DA, Richman DD, Vella S, Yeni PG, Volberding…
• The New York case: lessons being learned.
  Annals of internal medicine 2005 Volberding PA
• Anemia and HIV in the antiretroviral era: potential significance of testosterone.
  AIDS research and human retroviruses 2005 Behler C, Shade S, Gregory K, Abrams D, Volberding P
• Baboon bone-marrow xenotransplant in a patient with advanced HIV disease: case report and 8-year follow-up.
  Transplantation 2004 Michaels MG, Kaufman C, Volberding PA, Gupta P, Switzer WM, Heneine W, Sandstrom P, Kaplan L, Swift P, Damon L, Ildstad ST
• Epoetin alfa for treatment of anemia in HIV-infected patients: past, present, and future.
  Journal of acquired immune deficiency syndromes (1999) 2004 Henry DH, Volberding PA, Leitz G
• Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.
  The New England journal of medicine 2004 Chung RT, Andersen J, Volberding P, Robbins GK, Liu T, Sherman KE, Peters MG, Koziel MJ, Bhan AK, Alston B, Colquhoun D, Nevin T, Harb G, van der Horst C, AIDS Clinical Trials Group A5071 Study Team
• Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.
  JAMA 2004 Yeni PG, Hammer SM, Hirsch MS, Saag MS, Schechter M, Carpenter CC, Fischl MA, Gatell JM, Gazzard BG, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Schooley RT, Thompson MA, Vella S, Volberding…
• Anemia in HIV infection: clinical impact and evidence-based management strategies.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004 Volberding PA, Levine AM, Dieterich D, Mildvan D, Mitsuyasu R, Saag M, Anemia in HIV Working Group
• Initiating HIV therapy. Timing is critical, controversial.
  Postgraduate medicine 2004 Volberding PA
• Opportunities and options for treatment research in resource-constrained settings.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003 Volberding PA
• HIV therapy in 2003: consensus and controversy.
  AIDS (London, England) 2003 Volberding PA
• The pavia consensus statement.
  AIDS (London, England) 2003 Volberding PA, Murphy RL, Barbaro G, Barbarini G, Bruno R, Cirelli A, Currie PF, Di Lorenzo G, Fantoni M, Filiced G, Galli M, Grisorio B, Moroni M, Recusani F, Sacchi P, Scevola D, Stein JH, Torre D, …
• A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy.
  AIDS (London, England) 2003 Lalezari JP, Eron JJ, Carlson M, Cohen C, DeJesus E, Arduino RC, Gallant JE, Volberding P, Murphy RL, Valentine F, Nelson EL, Sista PR, Dusek A, Kilby JM
• Human immunodeficiency virus hematology.
  Hematology. American Society of Hematology. Education Program 2003 Volberding PA, Baker KR, Levine AM
• What can modeling tell us about the threat of antiviral drug resistance?
  Current opinion in infectious diseases 2002 Blower S, Volberding P
• Adherence, resistance, and timing: current issues in the use of new therapies.
  The AIDS reader 2002 Volberding P
• Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.
  JAMA 2002 Yeni PG, Hammer SM, Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schechter M, Schooley RT, Thompson MA, Vella S,…
• Does hepatitis C virus infection increase the risk of HIV disease progression?
  JAMA 2002 Rossi SJ, Volberding PA, Wright TL
• The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults.
  AIDS research and human retroviruses 2002 Kilby JM, Lalezari JP, Eron JJ, Carlson M, Cohen C, Arduino RC, Goodgame JC, Gallant JE, Volberding P, Murphy RL, Valentine F, Saag MS, Nelson EL, Sista PR, Dusek A
• Introduction: the importance of identifying and treating complications of human immunodeficiency virus disease.
  The Journal of infectious diseases 2002 Volberding P, Sullivan P
• The impact of anemia on quality of life in human immunodeficiency virus-infected patients.
  The Journal of infectious diseases 2002 Volberding P
• Who cares for AIDS?
  Journal of general internal medicine 2002 Volberding PA